Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. - Wikidata - wikimedia - TriplyDB

Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.

Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.

http://www.wikidata.org/entity/Q34015079

about

What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status.Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.Outcomes of serial dilation for high-grade radiation-related esophageal strictures in head and neck cancer patients.PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation Proton radiation therapy for head and neck cancer.Clinical application of intensity-modulated radiotherapy for head and neck cancer.Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study The treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters.Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.Current trends in initial management of oropharyngeal cancer: the declining use of open surgery.Proton beam radiation therapy for head and neck malignancies.Clinical heterogeneity and tumor control probability.Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.Robotic surgery for oropharynx cancer: promise, challenges, and future directions.IMRT and IGRT in head and neck cancer: Have we delivered what we promised?A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review.Impact of race on oropharyngeal squamous cell carcinoma presentation and outcomes among veterans.AHNS Series: Do you know your guidelines?Principles of radiation therapy for head and neck cancer: A review of the National Comprehensive Cancer Network guidelines.Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation.A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma.Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil.Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma.Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.Staging Neck Dissection and Transoral Robotic Surgery Treatment Algorithm in Palatine Tonsil Cancer.Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.Initial clinical experience with helical tomotherapy for head and neck cancer.Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.

P2860

Q27026269-7DD7F4B6-1CC8-4A1F-803D-4283E37E9731 Q30450366-DE1B0783-B817-4929-B4D0-16920CA3B659 Q33652561-F94287FA-8B94-4FDA-BFEB-894A72585BA1 Q33756093-A0EE2F46-E86B-4A34-84B6-F8B539337A16 Q34743124-1DF54F4E-7023-43BF-8F55-A5F3AF1E2484 Q34768949-016C9F74-8CE7-435A-88F6-802379E4D132 Q34974246-65746934-D873-4094-9151-89FB396EE264 Q35224516-6C6A16EC-D4A8-456F-A009-5354E088CEB1 Q35901104-E5A7DA55-89BB-4F7D-82E2-3948D20031AC Q36343896-95E94052-1657-4919-BBAB-DD20AE63D5DA Q36655507-6D204032-CD5E-4C5F-BCCD-B71A2780AA77 Q37169225-B1DAB5EA-46E2-4C6F-9C08-571E0D64CAAA Q37217016-1801667D-0EDD-48DC-9DBC-EB62D70788F4 Q37248881-71C5F56E-8F8F-40E6-AC90-4B1AA30442F2 Q37283393-AC112530-5753-451F-9532-0BF9A270B3D1 Q37337056-2A6A9700-21C7-4423-ADDE-00BB60933D47 Q37623578-7E4EC3A6-FFEC-43C6-9EC0-B7AA5C7F2989 Q37738175-0B91CFD3-E768-461E-A315-880CDF0919D7 Q37760509-844E9292-0FC0-4871-9445-6CF36632289D Q37799582-BFA46769-A39B-4268-8B1B-0B6F15C36A0B Q37981985-70CEADA4-06E9-4343-A6CC-7D78986ECECF Q38038841-2B83E15E-1079-42B4-A0D9-127DDD7B873C Q38204303-CA2A22B0-1D4A-4315-B1D5-EFD31CE17FF6 Q38225964-77BF30DB-B65C-4CBD-A05A-C93973D97A35 Q38788906-42D604A3-7903-4DEA-A8B6-CAC1A04C6866 Q39448913-22850CC8-BC22-4D31-997C-E48AA9E2F64E Q39843033-C36EB29B-9060-4158-8F6A-04BE0784C99F Q40681266-2C38807D-DDB6-495E-B272-57705740437B Q42419380-7CEED7F3-D84A-4C94-A7ED-BA60C383C08D Q44506873-ABA883A8-B6AC-4484-8FDB-11A8012236B3 Q44873720-A26FE8D6-3021-4E38-9173-0A2E9A91AFEF Q45919154-676B6EAB-EEFD-4ED2-A2C3-770839D4E494 Q46053548-58D6E920-F022-4E22-BB57-9935BCF151A6 Q46070865-D84E1FAB-5858-48A1-ADA6-528F7A74657B Q46330354-192C5116-C2B4-42AD-A16E-13292BC2849E Q46771718-A7E13AC8-4811-4724-83B6-A055E2B53125 Q46823759-7B19EC98-E3AD-4109-9E55-7E0F8C62ABC1 Q50619867-4C88E4C7-4CA1-431A-988D-614C841C456E

P2860

Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.

http://www.wikidata.org/entity/Q34015079

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@ast

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@en

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@nl

type

label

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@ast

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@en

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@nl

prefLabel

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@ast

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@en

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@nl

P1433

Q34015079-5796B923-DFA7-40E3-99BF-A987782E568F

P1476

Q34015079-0FD82471-2156-4451-9792-AED9B2F8B94D

P2093

Q34015079-296F78FF-85C4-49CD-BC4E-FB1F12CEDB1F

Q34015079-32B23CD6-3E26-4F8C-8972-3677604ACF74

Q34015079-4842AB00-A44D-4443-B565-A19F419108F0

Q34015079-5F07182A-FFA4-4958-B004-6051B0F0CED0

Q34015079-AB6C5CEB-198C-4704-87D1-9BC73BE2D435

Q34015079-CBFA4FCB-35D8-46F3-90C0-144D8B817249

Q34015079-FD12A9AF-D1CE-4BE3-97C8-1A4947AF1CD2

P2860

Q34015079-3740AA63-3F21-4AFC-A1C4-12C556666F32

Q34015079-3CF92EDB-FEFB-4D81-A391-D3660D9D7345

Q34015079-50E12CB4-3D37-44ED-B722-9C796F02CA10

Q34015079-58A61F20-EB7E-4DB6-A563-5CE6769DA0EF

Q34015079-A88694D8-975A-4760-B187-AF45F8F7778F

Q34015079-AC2D686F-A7D5-4E1B-A0A6-E819DA480EB1

Q34015079-B25697BE-F2E5-4570-813A-06D578B5238D

Q34015079-C5AAFEF5-C3BC-43CF-9CF0-4EB8C403E2CA

Q34015079-D164E24D-CD41-4BBC-AA7D-A30CC99CFAA8

Q34015079-E1715A7B-5C09-47A8-84FD-848CC386EF10

P304

Q34015079-CB56C2CD-2323-4275-B823-80C815F21B3E

P31

Q34015079-87F8A266-AF0F-487C-B827-AE5470C0D109

P356

Q34015079-1D55BDA2-551B-442C-ABF9-125929884CAC

P407

Q34015079-5E3F1CCE-7ABD-425E-966A-15F0CF69122C

P433

Q34015079-E46A3AAD-909F-4241-8742-9609D2CE62F7

P478

Q34015079-9E6AC4E7-C514-4577-9381-688E85F7C4AB

P50

Q34015079-30840867-0E63-42DD-8909-969D9EE15372

Q34015079-5A34BF63-89A6-420E-B0C0-0EE0ADAC998A

P577

Q34015079-91D02EF8-B61C-43DD-B9F4-51AFF96159F4

P5875

Q34015079-CF6D923B-2835-4C1F-840C-0E11333F21E0

P698

Q34015079-2D4790D4-F5B1-4031-B53F-582F25216785

P921

Q34015079-2BF4675F-02ED-4959-A30D-382F8F9EA5F5

P932

Q34015079-826E46DA-A7C8-4047-8765-D723434D153D

P356

J.IJROBP.2006.08.078

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Disease-control rates followin ...... imary oropharyngeal carcinoma.

@en

P2093

Adam S Garden

http://www.w3.org/2001/XMLSchema#string

Brian Mason

http://www.w3.org/2001/XMLSchema#string

George H Perkins

http://www.w3.org/2001/XMLSchema#string

K Kian Ang

http://www.w3.org/2001/XMLSchema#string

Pei-Fong Wong

http://www.w3.org/2001/XMLSchema#string

Sam S Tung

http://www.w3.org/2001/XMLSchema#string

William H Morrison

http://www.w3.org/2001/XMLSchema#string

P2860

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.

Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.

Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.

Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx.

Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.

Radiation therapy for early-stage carcinoma of the oropharynx.

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.

Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

P304

438-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2006.08.078

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

David I Rosenthal

P577

2006-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6656965

http://www.w3.org/2001/XMLSchema#string

P698

17141972

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4125020

http://www.w3.org/2001/XMLSchema#string